BioLife, a developer and supplier of class-defining bioproduction products and services for the cell and gene therapy (CGT) and broader biopharma markets, today announced the launch of a new, large-capacity controlled-rate freezer (CRF) to expand its CRF product line, which now stands at three different form factors. Branded as the IntelliRate i67C, this tabletop freezer fulfills a crucial customer need for higher volume production of cell therapies.
Todd Berard, BioLife's Chief Marketing Officer, commented, "With a capacity that's 40% larger than other tabletop CRFs, IntelliRate i67C is perfectly sized to efficiently scale precision rate freezing as a customer's capacity needs grow. We designed the IntelliRate i67C to increase single-batch, LN2 CRF capacity from mid- and late-stage clinical research to initial commercial manufacturing volumes. Fewer runs simplify the programming, setup, LN2 monitoring and power requirements, while the small footprint preserves valuable lab space."
The IntelliRate i67C features 67-liter (2.35 cu. ft.) volume inside the chamber, allowing for run capacities of 2,166 2mL vials, 26 (1 liter bag) to 104 (50mL bag) cassettes, or 272 canes. It boasts the largest touchscreen controller in its class to execute a wide range of preset and variable programming capabilities including the setup of repeatable, 21 CFR Part 11-compliant freeze profiles. The IntelliRate CRF also offers a range of options for enhanced multi-probe monitoring, racking and sample management.
